Preparation method of pH / photo-thermal response nano-particles MCN-coated CMCS and application of pH / photo-thermal response nano-particles in drug release

By combining pH and photothermal response performance in MCN@CMCS nanoparticles, the problem of difficulty in achieving controllable drug release under different pH conditions in the prior art is solved, and the drug delivery effect under different pH conditions is achieved, and through Photothermal stimulation further regulates the drug release rate, significantly improving the drug delivery effect of the carrier.

CN118975989APending Publication Date: 2024-11-19NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411066622.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-05
Publication Date
2024-11-19

AI Technical Summary

Technical Problem

The prior art is difficult to develop a nanocarrier capable of photothermal response under different pH conditions for drug delivery and drug release applications.

Method used

Using F-127 as a soft template and RF as the carbon source, MCN@CMCS nanoparticles with pH/photothermal response were prepared through one-step carbonization and amidation reaction, and combined with quercetin for drug delivery.

Benefits of technology

Nanocarriers that can be controlled-release drugs under different pH conditions are achieved, which enhances the drug loading rate and drug release performance of the drug, and further regulates the drug release rate through photothermal stimulation, significantly improving the drug delivery effect of the carrier.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118975989A_ABST
    Figure CN118975989A_ABST
Patent Text Reader

Abstract

The invention discloses a preparation method of pH / photo-thermal response nano-particles MCN-coated CMCS and application in drug release, and relates to the field of chemical drug synthesis, and the preparation method comprises the following steps: 1, preparing MCN; step 2, preparation of MCN-NH2 (Methyl Cellulose Nitride And step 3, preparing the MCN-coated CMCS. When the amidation reaction time of the CMCS and the MCN-NH2 is 18 hours, the optimal feeding ratio of the CMCS and the MCN-NH2 is 1: 4, the drug loading temperature is 30 DEG C, and the initial feeding concentration is 1000 mg.L <-1 >, the drug loading rate is 11.89%.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of chemical drug synthesis, and in particular to a method for preparing pH / photothermal responsive nanoparticles MCN@CMCS and their application in drug release. Background Art

[0002] Carboxymethyl chitosan (CMCS) is an important derivative of chitosan. It is widely used in gene therapy, drug delivery and tissue engineering due to its excellent biocompatibility, biodegradability, oxygenation and immunomodulatory properties. In addition, the surface of CMCS is rich in amino and carboxyl groups, and its hydrophilicity is further improved; under different pH conditions, -NH2 and -COOH will be protonated and deprotonated, which increases the degree of ionization between functional groups, thus having pH responsive properties.

[0003] Based on the pH sensitivity of CMCS and the photothermal conversion performance of MCN, F-127 was used as a soft template and RF as a carbon source. MCN was obtained by high-temperature one-step carbonization and de-templating. -NH2 was introduced by dehydration condensation of APTMS and the hydroxyl groups on the surface of MCN. The hydrophilic CMCS was grafted through amidation reaction to prepare a multifunctional carrier (MCN@CMCS) with photothermal and pH responsiveness. Summary of the invention

[0004] The purpose of the present invention is to prepare a pH / photothermal responsive nanoparticle MCN@CMCS and provide an application thereof in drug release.

[0005] The present invention adopts the following technical solution: preparing a unit of the particles in proportion, comprising the following steps:

[0006] Step 1, preparation of MCN: Under heating in a water bath at 30°C, weigh 0.1g of triblock copolymer F127 and dissolve it evenly in 20mL of deionized water; add 180mL of deionized water and 40mL of methanol to a three-necked flask, slowly add 2mL, 25wt% NH3·H2O to the mixed solution, stir evenly, slowly add the dissolved F-127, stir until the solution is uniform, add 0.6g of resorcinol and 0.8mL, 37wt% formaldehyde to the above solution and continue stirring for 6h; then centrifuge and separate the precipitate, wash it alternately with H2O / ethanol for several times, and dry it at 50°C overnight; the resulting product is a phenolic resin prepolymer-block copolymer composite, which is carbonized in a tubular furnace in a N2 atmosphere, and MCN is obtained by one-step high-temperature carbonization;

[0007] Step 2, preparation of MCN-NH2: Take 0.6g of MCN in a three-necked flask, add 200mL of methanol, stir for 15min until uniform, add 5.0mL of 3-aminopropyltrimethoxysilane APTMS dropwise, reflux for 8h in a N2 atmosphere at 80℃; after the reaction, collect the product by centrifugation, wash several times, and dry at 40℃ for 12h to obtain MCN-NH2;

[0008] Step 3, preparation of MCN@CMCS: place 50 mg of CMCS in a flask, then add 20 mL of deionized water, heat to 50°C, and stir evenly; add 50 mg of NHS and 75 mg of EDC, and activate for 4 hours; add 0.15 g of MCN-NH2 to the system, react for 10 hours, and then centrifuge to separate the product; wash and dry to obtain MSN@CMCS.

[0009] Furthermore, when the amidation reaction time of CMCS and MCN-NH2 was 18 h, the optimal feed ratio of CMCS to MCN-NH2 was 1:4, the drug loading temperature was 30 °C, and the initial drug concentration was 1000 mg·L- 1 The drug loading rate was 11.89%.

[0010] Application of pH / photothermal responsive nanoparticles MCN@CMCS combined with quercetin in drug release.

[0011] Beneficial effects of the present invention: The pH / photothermal responsive nanoparticles prepared by the present invention have a pH / photothermal responsive nanoparticles when the amidation reaction time of CMCS and MCN-NH2 is 18h, the optimal feed ratio of CMCS to MCN-NH2 is 1:4, the drug loading temperature is 30°C and the initial drug concentration is 1000mg·L- 1 The drug loading rate was 11.89%. BRIEF DESCRIPTION OF THE DRAWINGS

[0012] Figure 1 Schematic diagram of the preparation of HMCN@PEI-SAA;

[0013] Figure 2 Effect of amidation reaction time on drug loading efficiency;

[0014] Figure 3 The effect of CMCS and MCN-NH2 feed ratio on drug loading rate;

[0015] Figure 4 Effect of temperature on drug loading rate;

[0016] Figure 5 The effect of QU dosage on drug loading rate;

[0017] Figure 6 FT-IR images of MCN and MCN@CMCS;

[0018] Figure 7 Electron microscopy images and particle size distribution of MCN and MCN@CMCS;

[0019] In the figure: (a) - SEM image of MCN; (b) - TEM image of MCN; (c) - particle size distribution of MCN; (d) - SEM image of MCN@CMCS; (e) - TEM image of MCN@CMCS; (f) particle size distribution of MCN@CMCS

[0020] Figure 8 Potential diagrams of MCN, MCN-NH2, and MCN@CMCS;

[0021] Fig. 9 Adsorption thermodynamic curve and model fitting diagram of MCN@CMCS;

[0022] In the figure: (a)—Adsorption thermodynamic curve of MCN@CMCS; (b)—Langmuir model;

[0023] (c)—Freundlich model; (d)—Temkin model

[0024] Fig.10 Adsorption kinetics curve and model fitting diagram of MCN@CMCS;

[0025] In the figure: (a)—Adsorption kinetic curve of MCN@CMCS; (b)—Pseudo-first-order kinetic model;

[0026] (c)—quasi-second-order kinetic model; (d)—intra-particle diffusion model

[0027] Fig.11 Drug release curves of QU@MCN@CMCS at different pH values;

[0028] Fig.12 Drug release of QU@MCN@CMCS. DETAILED DESCRIPTION

[0029] Embodiment 1:

[0030] like Figure 1 The preparation process of MCN@CMCS shown in the figure:

[0031] 1) Preparation of MCN

[0032] Under heating in a water bath at 30°C, weigh 0.1g of triblock copolymer F127 and dissolve it evenly in 20mL of deionized water. Add 180mL of deionized water and 40mL of methanol to a 250mL three-necked flask, slowly add NH3·H2O (2mL, 25wt%) to the mixed solution, stir evenly, slowly add the dissolved F-127, stir for 15min until the solution is uniform, add resorcinol (0.6g) and formaldehyde (0.8mL, 37wt%) to the above solution and continue stirring for 6h. Then centrifuge and separate the precipitate, wash it alternately with H2O / ethanol several times, and dry it at 50°C overnight. The resulting product is a phenolic resin prepolymer-block copolymer composite, which is carbonized in a tubular furnace in a N2 atmosphere at a heating rate of 5°C·min- 1 , raised to 700℃, carbonized for 4h, and MCN was obtained by one-step high-temperature carbonization.

[0033] 2) Preparation of MCN-NH2

[0034] Take 0.6g of MCN in a three-necked flask, add 200mL of methanol, stir for 15min until uniform, add 5.0mL of 3-aminopropyltrimethoxysilane (APTMS) dropwise, and reflux for 8h in a N2 atmosphere at 80℃. After the reaction is completed, collect the product by centrifugation, wash several times, and dry at 40℃ for 12h to obtain MCN-NH2.

[0035] 3) Preparation of MCN@CMCS

[0036] Place 50 mg of CMCS in a flask, add 20 mL of deionized water, heat to 50 °C, and stir evenly. Add 50 mg of NHS and 75 mg of EDC and activate for 4 h. Add 0.15 g of MCN-NH2 to the system, react for 10 h, and centrifuge to separate the product. Wash and dry to obtain MSN@CMCS.

[0037] Optimization of drug loading process of MCN@CMCS

[0038] The effects of amidation reaction time, CMCS and MCN-NH2 feed ratio, drug loading temperature and QU concentration on MCN@CMCS drug loading rate were investigated in turn to explore the optimal conditions for the preparation of MCN@CMCS.

[0039] 1) Effect of amidation reaction time on drug loading efficiency

[0040] In order to investigate the optimal duration of the amidation reaction between CMCS and MCN-NH2, the experimental conditions were set as a drug loading temperature of 30 °C and a drug concentration of 1000 mg·L- 1Under the condition that the mass ratio of CMCS to MCN-NH2 was 1:4, the amidation reaction time of CMCS and MCN-NH2 was set to 6h, 12h, 18h, 24h and 30h. The drug loading rate was calculated after centrifugation. The results are shown in Figure 2 shown.

[0041] from Figure 2 It can be seen that with the increase of the amidation reaction time of CMCS and MCN-NH2, the drug loading rate shows a trend of first increasing and then decreasing. When the amidation reaction time reaches 18h, the drug loading rate reaches a maximum of 12.3%. This phenomenon may be due to the increase in the amidation reaction time in the early stage of the reaction, the grafting rate of CMCS increases, and then the porous structure of CMCS can adsorb more drug molecules. As time goes on, the reaction sites on the carrier surface are exhausted by the reaction or blocked by the grafted CMCS, and the excess CMCS enters the carrier pores, causing the pores to be blocked, resulting in a decrease in the drug loading rate during the reaction time of 18 to 30h. Therefore, the optimal amidation reaction time of CMCS and MCN-NH2 is 18h.

[0042] 2) Effect of CMCS and MCN-NH2 feed ratio on drug loading rate

[0043] In order to investigate the optimal feed ratio of CMCS and MCN-NH2, the experiment was set at a loading temperature of 30 °C and a feed concentration of 1000 mg·L- 1 Under the condition of 18h amidation reaction between CMCS and MCN-NH2, the feed ratio of CMCS to MCN-NH2 was set to 1:1, 1:2, 1:3, 1:4 and 1:5. After centrifugation, the absorbance was measured to calculate the drug loading rate. The results are as follows Figure 3 shown.

[0044] from Figure 3 It can be found that when the amount of MCN-NH2 is kept constant, as the amount of CMCS is reduced, the drug loading rate increases first and then decreases. CMCS :M MCN-NH2 =1:4, the drug loading rate reaches 14.2%. This may be due to the fact that under the premise of maintaining the quality of MCN-NH2 unchanged, when the feed ratio is large, CMCS is in an excessive state, and the pore obstruction effect of some CMCS is aggravated, resulting in a relatively low drug loading rate. When the feed ratio of CMCS to MCN-NH2 is 1:4, CMCS is in an appropriate state. While not affecting the pore drug loading, the drug loading efficiency of the void structure of CMCS reaches the best. With the further reduction of CMCS, the overall drug loading efficiency of the carrier decreases due to the lack of void drug loading of CMCS. Therefore, the optimal feed ratio of CMCS to MCN-NH2 is 1:4.

[0045] 3) Effect of drug loading temperature on drug loading rate

[0046] In order to investigate the optimal adsorption temperature of the carrier drug, the experiment was set at a drug concentration of 1000 mg·L- 1 , CMCS and MCN-NH2 were amidated for 18 h and the mass ratio of CMCS to MCN-NH2 was 1:4. The carrier drug loading temperature was set at 25°C, 30°C, 35°C, 40°C and 45°C. The absorbance value was measured to calculate the drug loading rate. The results are as follows Figure 4 shown.

[0047] from Figure 4 It can be seen that between 25 and 30 °C, the drug loading rate of MCN@CMCS does not increase significantly. At 30 °C, the drug loading rate reaches a maximum of 12.45%. Between 30 and 45 °C, the drug loading rate shows a downward trend with the increase of temperature. This may be due to the excessively high temperature causing the microscopic molecular thermal motion of the drug and the carrier to intensify, the adsorption and diffusion balance of the drug molecules in the drug loading system is broken, and the diffusion amount of the drug is greater than the adsorption amount of the carrier. Therefore, it is believed that the drug loading effect is better when the drug loading temperature is 30 °C.

[0048] 4) Effect of dosage on drug loading rate

[0049] In order to investigate the optimal dosage of the model drug, the experiment was set at a loading temperature of 30°C and a dosage concentration of 1000 mg·L- 1 , CMCS and MCN-NH2 amidation reaction for 18h and the mass ratio of CMCS to MCN-NH2 was 1:4, and the QU dosage was set to 200mg·L- 1 , 400mg·L- 1 、600mg·L- 1 , 800mg·L- 1 and 1000mg·L- 1 and 1200mg·L- 1 The remaining drug absorption concentration was measured by UV spectrophotometer and the drug loading rate was calculated. Figure 5 shown.

[0050] from Figure 5 It can be seen that the increase in dosage leads to an increase in drug loading rate. When the dosage is 1000 mg·L- 1 When the drug loading rate gradually stabilized, the maximum drug loading rate reached 11.89%. With the increase of drug dosage, the free adsorption sites of the carrier gradually decreased. 1 The drug loading rate reaches saturation when the dosage increases. Thereafter, the drug loading rate no longer changes significantly, and the drug loading system is in an adsorption equilibrium state.

[0051] FT-IR analysis

[0052] The structures of MCN and MCN@CMCS were characterized by infrared spectroscopy, and the surface group composition of the carrier was analyzed. Figure 6 shown.

[0053] In the MCN spectrum, 3450cm -1 The peak at 3450cm is the stretching vibration peak of the phenolic hydroxyl group in MCN; -1 The peak enhancement at 2973 cm is mainly due to the superposition of NH2 stretching vibration in CMCS and NH stretching vibration in amide. -1 The absorption peak at 1725cm is mainly the stretching vibration peak of -CH2 in MCN. -1 The absorption peak is the stretching vibration peak of the carboxyl group in the amidated CMCS molecular structure.

[79] .

[0054] SEM and TEM analysis

[0055] The particle microstructures of MCN and MCN@CMCS were analyzed by SEM and TEM. Figure 7 As shown. Figure 7 (a) and Figure 7 As can be seen from (c), the MCN has a regular spherical shape, an average particle size of about 186.2 nm, and a relatively concentrated particle size distribution. Figure 7 Part of the pore structure of MCN can be observed in (b), and the boundaries between carriers are clear, proving the successful preparation of MCN. Figure 7 In (d), (e) and (f), it can be found that the morphology of MCN@CMCS is spherical, and the average particle size increases to 204.8 nm. The microscopic morphology is different from that of MCN mainly in the translucent organic modification layer on its surface. There is adhesion between the carriers, and the boundary of MCN@CMCS becomes relatively blurred.

[0056] Zeta potential analysis

[0057] The surface potential of MCN, MCN-NH2 and MCN@CMCS was analyzed by Zeta potential analyzer to verify the grafting of -NH2 and CMCS. The results are as follows Figure 8 shown.

[0058] from Figure 8 It can be seen that the potential of MCN is negative, which may be due to the deprotonation of the phenolic hydroxyl and alcoholic hydroxyl groups on the surface. MCN-NH2 shows a positive charge because -NH2 is protonated to -NH3+. After amidation modification, the carrier potential becomes negative again. It can be inferred that this is because CMCS forms an amide bond with -NH2 in MCN-NH2, and -NH2 is consumed. Secondly, the deprotonation of -COOH carried by CMCS itself realizes the negative surface potential of the carrier.

[0059] Taking drug loading as the standard, the optimal preparation process was explored. When the amidation reaction time of CMCS and MCN-NH2 was 18 h, the optimal feed ratio of CMCS to MCN-NH2 was 1:4, the drug loading temperature was 30 °C, and the initial drug concentration was 1000 mg·L- 1 When , the drug loading performance reached a better state, and the drug loading rate was 11.89%.

[0060] 2) The structure and performance of the carrier were analyzed by FT-IR, SEM, TEM and Zeta potential. According to the FT-IR results, it is inferred that MCN and MCN@CMCS were successfully prepared; the Zeta potential results show that the difference in potential between MCNMCN-NH2 and MCN@CMCS can be inferred that MCN@CMCS was successfully prepared; SEM and TEM show that MCN and MCN@CMCS are nanocarriers with uniform particles and the average particle size of the modified MCN@CMCS increased from about 186.2nm to 204.8nm.

[0061] In order to investigate the adsorption performance and mechanism of MCN@CMCS for model drugs, the relationship between the equilibrium adsorption amount of MCN@CMCS and QU concentration was explored. The model and fitting results are shown in Fig. 9 and Table 1.

[0062] Depend on Fig. 9 (a) It can be seen that when the QU concentration is 100 to 1200 mg·L- 1 In the range of 800~1200mg·L- 1 In the range of 1000 mg·L- 1 When the equilibrium adsorption capacity reached the maximum value, it tended to be stable and reached 141.91 mg·L- 1 , which is mainly due to the fact that the adsorption sites reach saturation in the late stage of adsorption.

[0063] Table 1 Adsorption thermodynamic parameters of MCN@CMCS

[0064]

[0065] The Langmuir, Freundlich and Temkin models were used for fitting analysis to explore the adsorption mechanism of MCN@CMCS. Fig. 9 (b), (c) and (d) and Table 1 show that the fitting degree of the Freundlich isotherm adsorption equation is better than that of the other three models, and R 2(0.983) is closer to 1, indicating that the adsorption mechanism of MCN@CMCS is more consistent with the Freundlich isotherm adsorption equation. It can be inferred that the adsorption of MCN@CMCS is mainly multi-molecular layer adsorption.

[0066] Adsorption kinetics and mechanism studies

[0067] According to the relationship between the equilibrium adsorption amount and time of MCN@CMCS, the adsorption kinetic curve was established and fitted. The results are shown in Fig.10 And as shown in Table 2.

[0068] from Fig.10 As can be seen from (a), the adsorption amount of MCN@CMCS gradually increases with time. In the adsorption time of 0-480 min, the adsorption rate of MCN@CMCS remains in a high range, which may be caused by the physical adsorption of the carrier mesopores. In the range of 480-1440 min, the adsorption rate of the carrier slows down and basically maintains a stable adsorption rate. In the range of 1440-2880 min, the adsorption amount of the carrier remains basically unchanged, reaching a maximum adsorption amount of 128.91 mg·g -1 In order to explore the adsorption mechanism of MCN@CMCS, pseudo-first-order and pseudo-second-order kinetic models and intra-particle diffusion models were used for fitting. The results are shown in Fig.10 (b), (c), (d) and Table 2.

[0069] Table 2 Adsorption kinetic parameters of MCN@CMCS

[0070]

[0071] As can be seen from Table 2, the R 2 0.934, 0.998 and 0.743 respectively, and the fitting degree of pseudo-second-order kinetics (R 2 =0.998) is closer to 1, and the calculated qei is close to the experimental equilibrium adsorption amount. It can be inferred that the adsorption process of QU by MCN@CMCS is more consistent with pseudo-second-order kinetics. At the same time, according to the kinetic adsorption curve, the adsorption rate is higher in the early stage of adsorption, which can be inferred that the adsorption process of QU by the carrier is mainly chemical adsorption.

[0072] Study on drug release performance of QU@MCN@CMCS

[0073] 1) Drug release properties of QU@MCN@CMCS at different pH

[0074] In the simulated body fluid environment with different pH values ​​(5.0, 6.5, 7.4), the release performance of QU@MCN@CMCS in buffer solutions with different pH values ​​was investigated with pH as a variable. The results are as follows: Fig.11 shown.

[0075] from Fig.11 It can be seen that after 48 h, the cumulative drug release rates of the carrier QU@MCN@CMCS in the simulated pH body fluid environment were 10.37%, 12.18% and 13.34%, respectively. It can be shown that with the decrease of pH, the cumulative drug release rate gradually increases, indicating that QU@MCN@CMCS has certain pH response performance. Among them, the overall cumulative drug release rate of QU@MCN@CMCS was low in an environment simulating normal healthy tissue fluid (pH=7.4), which may be because in a neutral environment, the chemical properties of CMCS are relatively stable, and it has a strong blocking effect on the mesoporous channels of the carrier, resulting in an increase in the resistance to drug release; in an environment simulating diseased tissue fluid (pH=6.5), the drug release performance of the carrier was improved, which may be due to the protonation of -NH2 in CMCS in an acidic environment, the hydrophilicity increased, and the part of CMCS blocking the pores stretched due to electrostatic repulsion, reducing the drug release resistance and improving the drug release performance; in an environment simulating diseased cell fluid (pH=5.0), its drug release rate was significantly improved, which may be due to the aggravated protonation degree of -NH2 in CMCS on the carrier surface, which further weakened the blocking effect of the pores and further improved the drug release performance.

[0076] 2) Drug release performance of QU@MCN@CMCS under NIR irradiation

[0077] Two groups of control experiments were conducted on the drug release performance of QU@MCN@CMCS in simulated body fluids with different pH values ​​under the conditions of NIR irradiation and non-irradiation. The results are as follows: Fig.12 shown.

[0078] from Fig.12 It can be seen that the cumulative drug release rate of the experimental group with NIR application in 4-12h is higher than that of the control group without NIR application; in the period of 8-48h, the cumulative drug release rate of each experimental group irradiated by NIR is higher than that of the experimental group without NIR irradiation, among which the cumulative drug release rate of QU@MCN@CMCS under the condition of pH=5.0+NIR for 48h is 18.87%, which is higher than the cumulative drug release rate under the condition of pH=5.0. The drug release rate of the carrier under pH=6.5+NIR and pH=7.4+NIR is 16.31% and 13.08%, respectively, which is also higher than that of the experimental group without NIR application under the same pH conditions. The reason for the above phenomenon may be that during the NIR irradiation process, the carrier undergoes photothermal conversion, the temperature of the carrier surface and internal pores rises, the thermal motion of the drug molecules intensifies, and it is easier to disperse in the dispersion medium, and the drug release rate is improved. The study shows that QU@MCN@CMCS has photothermal controllability.

Claims

1. Preparation method of pH / photothermal responsive nanoparticles MCN@CMCS, characterized in that: The method of preparing one unit of the granules in proportion comprises the following steps: Step 1, preparation of MCN: Under heating in a water bath at 30 °C, weigh 0.1 g of triblock copolymer F127 and dissolve it evenly in 20 mL of deionized water; add 180 mL of deionized water and 40 mL of methanol to a three-necked flask, slowly add 2 mL, 25 wt% NH3·H2O to the mixed solution, stir evenly, slowly add the dissolved F-127, stir until the solution is uniform, add 0.6 g of resorcinol and 0.8 mL, 37 wt% formaldehyde to the above solution and continue stirring for 6 h; then centrifuge to separate the precipitate, wash it alternately with H2O / ethanol several times, and dry it at 50 °C overnight; the obtained product is a phenolic resin prepolymer-block copolymer composite, which is carbonized in a tubular furnace in a N2 atmosphere, and MCN is obtained by one-step high-temperature carbonization; Step 2, preparation of MCN-NH2: Take 0.6 g of MCN in a three-necked flask, add 200 mL of methanol, stir for 15 min until uniform, add 5.0 mL of 3-aminopropyltrimethoxysilane APTMS dropwise, reflux for 8 h in a N2 atmosphere at 80 °C; after the reaction is completed, collect the product by centrifugation, wash several times, and dry at 40 °C for 12 h to obtain MCN-NH2; Step 3, preparation of MCN@CMCS: Place 50 mg of CMCS in a flask, then add 20 mL of deionized water, heat to 50 °C, and stir evenly; add 50 mg of NHS and 75 mg of EDC, and activate for 4 h; add 0.15 g of MCN-NH2 to the system, react for 10 h, and then centrifuge to separate the product; wash and dry to obtain MSN@CMCS.

2. The method for preparing pH / photothermal responsive nanoparticles MCN@CMCS according to claim 1, characterized in that: When the amidation reaction time of CMCS and MCN-NH2 was 18 h, the optimal feed ratio of CMCS to MCN-NH2 was 1:4, the loading temperature was 30 ℃ and the initial dosage concentration was 1000 mg·L -1 The drug loading rate was 11.89%.

3. Application of pH / photothermal responsive nanoparticles MCN@CMCS combined with quercetin in drug release.